Recent studies have found that the GlyNAC complex can correct GSH deficiency, counteract oxidative stress, correct type II diabetes, reduce insulin resistance, enhance muscle strength, and improve cognitive function in older adults, suggesting that it has anti-aging effects [28,29,30]
In this review, we summarize the recent advances in the regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy and explore the prospect of combining Nrf2 inhibitors and ferroptosis inducers as a promising cancer treatment strategy
In the 72-week non-diabetic obesity trial, adults lost -15.0% at 5 mg, -19.5% at 10 mg, and -20.9% at 15 mg. Real-world outcomes vary because dose reached, adherence, and baseline state vary
Yes, it is completely normal